Enter assignee name

Forward Citations = 336

Loading Chart...

8 inventors (with patents filed for the assignee):

John R Murphy (3 out of 16 patents)

Patricia A Bacha (3 out of 3 patents)

Jean C Nichols (2 out of 2 patents)

4. Jean-Francois Bach (1 out of 9 patents)

5. Terry Barton Strom (1 out of 35 patents)

6. Leonard F Estis (1 out of 1 patent)

7. Vicki E Rubin-Kelley (1 out of 1 patent)

8. Serene E Forte (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 6074636 - Method of using cell surface receptor targeted molecules for the (2000-06-13),

2. 6022950 - Hybrid molecules having translocation region and cell-binding region (2000-02-08),

3. 5965406 - Recombinant DNAS encoding three-part hybrid proteins (1999-10-12),

4. 5906820 - Epidermal growth factor receptor targeted molecules for treatment of (1999-05-25),

5. 5684221 - Mammalian model of a malignant disorder (1997-11-04),

6. 5668255 - Hybrid molecules having translocation region and cell-binding region (1997-09-16),

7. 5614488 - Epidermal growth factor receptor targeted molecules for treatment of (1997-03-25),

8. 5571507 - Methods of treating diabetes (1996-11-05),

9. 5110912 - Purification of Il-2-containing hybrid compounds (1992-05-05),

Seragen, Inc. is a biotechnology company focused on developing innovative therapies for rare and serious diseases. Our mission is to bring life-changing treatments to patients in need. With a strong pipeline of potential breakthrough drugs, we are dedicated to advancing research and improving healthcare outcomes.

Profile summary based on public USPTO records.